Shirley W. Chan

102, Pokfulam Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: Prediction models and use of machine learning.

Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: Prediction models and use of machine learning.

Journal: Joint bone spine

Published: March 30, 2026

Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: prediction models and use of machine learning.

Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: prediction models and use of machine learning.

Journal: Joint bone spine

Published: March 30, 2026

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Journal: Drug safety

Published: December 12, 2025

Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study.

Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study.

Journal: Arthritis research & therapy

Published: December 10, 2025

Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990-2025.

Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990-2025.

Journal: Seminars in arthritis and rheumatism

Published: December 01, 2025

Deep learning algorithm for semiquantification of spinal inflammation in axial spondyloarthritis.

Deep learning algorithm for semiquantification of spinal inflammation in axial spondyloarthritis.

Journal: RMD open

Published: September 29, 2025

Predicting Infection Risk in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs: An Application of Machine Learning.

Predicting Infection Risk in Rheumatoid Arthritis Patients Treated with Biological and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs: An Application of Machine Learning.

Journal: Studies in health technology and informatics

Published: August 08, 2025

Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study.

Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study.

Journal: Arthritis care & research

Published: June 25, 2025

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study.

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study.

Journal: Arthritis care & research

Published: June 25, 2025

Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study.

Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study.

Journal: Lupus science & medicine

Published: June 20, 2025

A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.

A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.

Journal: Kidney international

Published: May 24, 2025

The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021.

The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021.

Journal: Journal of translational autoimmunity

Published: April 17, 2025

Showing 1-12 of 48

Last Updated: 09/26/2026